Prolonged loss of consciousness and elevated porphyrins following propofol administrations

Anesthesiology

Volumn 89, Issue 4, 1998, Pages 1029-1031

  Asirvatham, Sam J ^a   Johnson, Tom W ^b   Oberoi, Mohinder P ^b   Jackman, Warren M ^b  

^a MAYO CLINIC   (United States)

^b NONE

Author keywords

Ablation; Neurological deficits; Ventricular tachycardia

Indexed keywords

AMINOLEVULINIC ACID; COPROPORPHYRIN; GLUCOSE; PORPHOBILINOGEN; PORPHYRIN; PROPOFOL;

ADULT; ANESTHESIA; ARTICLE; CASE REPORT; CATHETER ABLATION; HEART VENTRICLE TACHYCARDIA; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; NEURALGIA; NEUROLOGIC DISEASE; NEUROPATHY; PORPHYRIA; PRIORITY JOURNAL; SEDATION; UNCONSCIOUSNESS;

ADULT; AMINOLEVULINIC ACID; ANESTHETICS, INTRAVENOUS; COPROPORPHYRINS; HUMANS; MALE; PORPHOBILINOGEN; PORPHYRINS; PROPOFOL; UNCONSCIOUSNESS;

EID: 0031662661     PISSN: 00033022     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000542-199810000-00031     Document Type: Article

References (12)

1. Weir PM, Hodkinson BP: Is propofol a safe agent in porphyria? Anaesthesia 1988; 43:1022-3
2. Sorkin FB: Propofol. An overview of its pharmacology and a review of its clinical efficacy in intensive care sedation. Drugs 1995; 50(4):636-57
3. Lim HW, Murphy GM: The porphyrias. Clin Dermatol 1996 14(4): 375-87
4. Suarez JI, Cohen ML, Larkin J, Kernich CA, Hricik DE, Daroff RB: Acute intermittent porphyria: Clinicopathologic correlation. Report of a case and review of the literature. Neurology 1997 48(6):1678-89
5. Braunwald E, Isselbacher KJ, Pelersdorf RG, Wilson JD, Martin JB, Fauci AS: Harrison's Principles of Internal Medicine, 11th edition. McGraw-Hill, 1987, pp 1638-43
6. Elcock D, Norris A: Elevated porphyrins following propofol anaesthesia in acute intermittent porphyria. Anaesthesia 1994 49(11): 957-8
7. Harrison GG, Meissner PN, Hift RJ: Anaesthesia for the porphyric patient. Anaesthesia 1993; 48:417-21
8. Hughes PJ: Propofol in acute porphyrias. Anaesthesia 1990; 45: 415
9. Allen KR, Rushworth PA, Degg TJ, Barth JH: Measurement of urinary porphobilinogen and porphyrins: V. Preliminary data from a pilot QA scheme. Ann Clin Biochem 1997; 34:553-5
10. Hahn M, Bankovsky HL: Multiple chemical sensitivity syndrome and porphyria. A note of caution and concern. Arch Intern Med 1997; 157(3):281-5
11. National Medical Services. Reference laboratory. Willow Grove, Pennsylvania
12. Mitterschiffthaler G, Theiner A, Hetzel H, et al: Safe use of propofol in a patient with acute intermittent porphyria. Br J Anaesth 1988; 60:109-11